Explained | XBB.1.16, the Omicron recombinant behind India’s new COVID spike - The Hindu
- Explained | XBB.1.16, the Omicron recombinant behind India’s new COVID spike The Hindu
- Next-gen Mpro inhibitor: Promising new drug candidate against Omicron and other SARS-CoV-2 variants News-Medical.Net
- New SARS-CoV-2 target could boost immunity against all coronaviruses Medical Xpress
- COVID Virus Is 'Warming Up' to Produce New Recombinant Strains: IISc Scientist | Weather.com The Weather Channel
- Study provides insights on stability of SARS-CoV-2 in biological fluids of animals News-Medical.Net
- View Full Coverage on Google News